NCT02679794

Brief Summary

The 2010 Dietary Guidelines for Americans emphasizes consumption of 4.5 cups of fruits and vegetables daily but the average intake of US adults is only 2.6 cups. This low consumption of fruits and vegetables results in a limited availability of certain nutrients found in these foods such as carotenoids. Dietary carotenoids have health-promoting properties and are known to fight against disease. Although, maintaining adequate vitamin D status is critical for overall skeletal health and the prevention of osteoporosis, vitamin D insufficiency is also widespread in the United States. Eggs, egg yolk in particular, are known to be a good source of lipid and may improve the absorption of carotenoids and vitamin D found in co-consumed vegetables in young and older women. Therefore, the investigators are interested to see if consuming eggs with cooked vegetables will increase carotenoids and vitamin D absorption.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 4, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 10, 2016

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

January 11, 2018

Status Verified

January 1, 2018

Enrollment Period

1.4 years

First QC Date

February 4, 2016

Last Update Submit

January 9, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Contents of total and individual carotenoids in triglyceride-rich lipoprotein fractions

    composite 0-10 h area under the curve of total and individual carotenoids (lutein, zeaxanthin, alpha-carotene, beta-carotene, lycopene) in triglyceride-rich lipoprotein fractions (all units are nmol/L x 10 hours)

    From hour 0 to hour 10

  • Vitamin D content in in triglyceride-rich lipoprotein fractions

    composite 0-10 h area under the curve of vitamin D2, vitamin D3, 25(OH)D2, and 25(OH)D3 in triglyceride-rich lipoprotein fractions (all units are nmol/L x 10 hours)

    From hour 0 to hour 10

Study Arms (2)

Egg consumption

EXPERIMENTAL

Consuming sautéed vegetables and 3g canola oil with 100g (2 large eggs) of whole eggs

Behavioral: Egg consumption

Control

PLACEBO COMPARATOR

Consuming sautéed vegetables and 3g canola oil without eggs

Behavioral: Control

Interventions

Egg consumptionBEHAVIORAL

Subjects will consume a carefully portioned sautéed vegetables and 3g canola oil with 100g (2 large eggs) of whole eggs

Egg consumption
ControlBEHAVIORAL

Subjects will consume a carefully portioned sautéed vegetables and 3g canola oil.

Control

Eligibility Criteria

Age19 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pre- (regularly menstruating, aged 19-45y) and post-menopausal (aged 60+y) females
  • weight stable (± 3 kg in the past 3 months)
  • constant habitual activity patterns within last 3 months
  • no acute illness
  • not diabetic or have chronic diseases known to influence lipid or energy metabolism
  • blood 25(OH)D\>20 nmol/L
  • non-smoking
  • drinking no more than 2 alcoholic drinks per day
  • not taking estrogen-based birth control or osteoporosis prevention or treatment medications in the past 3 months
  • not taking lipid-lowering medications

You may not qualify if:

  • Males
  • age \<19 or age \>45y for pre-menopausal women and age \<60y for post-menopausal women
  • weight change\>3 kg in the past 3 months
  • exercising vigorously over the past 3 months
  • intestinal disorders including lipid malabsorption or lactose intolerance
  • abnormal liver or kidney function tests
  • blood 25(OH)D\<20 nmol/L
  • fasting blood glucose\>110 mg/dL
  • smoking
  • drinking more than 2 alcoholic drinks per day
  • taking estrogen-based birth control or osteoporosis prevention or treatment medications in the past 3 months
  • taking lipid-lowering medications affecting plasma cholesterol concentration

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Purdue Clinical Research Center

West Lafayette, Indiana, 47907, United States

Location

Study Officials

  • Wayne W Campbell, Ph.D.

    Purdue University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Wayne Campbell, Ph.D.

Study Record Dates

First Submitted

February 4, 2016

First Posted

February 10, 2016

Study Start

December 1, 2015

Primary Completion

May 1, 2017

Study Completion

August 1, 2017

Last Updated

January 11, 2018

Record last verified: 2018-01

Locations